KR920004485A - New Compositions Composed of Hydrophilic Polymers and Different Hydrophilic Materials - Google Patents

New Compositions Composed of Hydrophilic Polymers and Different Hydrophilic Materials Download PDF

Info

Publication number
KR920004485A
KR920004485A KR1019910014321A KR910014321A KR920004485A KR 920004485 A KR920004485 A KR 920004485A KR 1019910014321 A KR1019910014321 A KR 1019910014321A KR 910014321 A KR910014321 A KR 910014321A KR 920004485 A KR920004485 A KR 920004485A
Authority
KR
South Korea
Prior art keywords
composition
starch
phase
cellulose
hydrophilic polymer
Prior art date
Application number
KR1019910014321A
Other languages
Korean (ko)
Inventor
실비거 자콥
토마스 코울 에워트
에글리 마르쿠스
Original Assignee
다니엘 에이. 스콜라
워너-램버트 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다니엘 에이. 스콜라, 워너-램버트 컴퍼니 filed Critical 다니엘 에이. 스콜라
Publication of KR920004485A publication Critical patent/KR920004485A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

내용 없음No content

Description

친수성 중합체 및 이와 상이한 친수성 물질로 이루어진 신규 조성물New Compositions Composed of Hydrophilic Polymers and Different Hydrophilic Materials

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (30)

고체화된 친수성 중합체로 이루어진 매체 및 친수성 중합체로 이루어진 매체에 용해되지 않는 최소한 하나의 친수성 물질로 이루어진 상을 포함하며, 매체는 상에 대해 분산매체로서 작용하고, 상은 이와 마찬가지고 매체에 대해 분산상으로서 작용하며, 상은 이러한 상이 없는 조성물로 만들어진 용해 속도와 비교해볼때 제품의 용해도를 증가시키기에 충분한 농도로 조성물내에 존재하는, 크기 안정성이 상당히 양호하고 용해성이 향상된 제품으로 만들어질 수 있는 물질로 구성된 조성물.A medium comprising a solidified hydrophilic polymer and a phase consisting of at least one hydrophilic material that is insoluble in the medium consisting of the hydrophilic polymer, the medium acting as a dispersion medium for the phase, and the phase likewise acting as a dispersed phase for the medium And the phase is composed of a material which can be made into a product with significantly good size stability and improved solubility, present in the composition at a concentration sufficient to increase the solubility of the product as compared to the dissolution rate made with such a phaseless composition. 제1항에 있어서, 친수성 물질이 흡습성 물질로 이루어진 조성물.The composition of claim 1 wherein the hydrophilic material consists of a hygroscopic material. 제1항 또는 제2항에 있어서, 성분들의 분말 혼합물 형태, 용융물 형태 및 용융물로부터 얻어질 수 있는 고체화된 형태로부터 선택된 형태의 조성물.The composition according to claim 1 or 2, wherein the composition is in a form selected from the form of a powder mixture of the components, from the melt form and from the solidified form obtainable from the melt. 전기한 항의 어느 한 항에 있어서, 용융물로부터 얻어진 것으로서 분말, 펠렛 및 과립으로부터 선택된 형태의 조성물.The composition according to any one of the preceding claims, wherein the composition is obtained from a melt and in the form selected from powders, pellets and granules. 전기한 항의 어느 한 항에 있어서, 친수성 중합체가 분산상을 만들지 않는 조건으로, 동물성 젤라틴, 식물성 젤라틴, 해바라기 단백질, 간장콩 단백질, 목화씨 단백질, 땅콩 단백질, 평지씨 단백질, 아크릴화된 단백질로부터 선택된 수용성 단백질; 실제적으로 수용성인 다당류, 알킬전분, 하이드록시알킬 전분 및 하이드록시알킬알킬전분, 전분 에스테르 및 하이드록시알킬 전분 에스테르, 카복시알킬전분, 카복시알킬알킬 전분 알킬 셀룰로즈, 하이드록시알킬 셀룰로즈 및 하이드록시알킬알킬 셀룰로즈, 셀룰로즈에스테르 및 하이드록시알킬 셀룰로즈 에스테르, 카복시알킬 셀룰로즈, 카복시알킬알킬 셀룰로즈 및 이것의 알카리 금속염, 폴리아크릴산 및 폴리아크릴산에스테르, 폴리메타크릴산 및 폴리메타크릴산 에스테르, 폴리비닐알콜, 폴리비닐 아세테이트 프탈레이트(PVAP), 폴리크로톤산; 폴리이타콘산, 폴리말레인산; 4차화될 수 있는 3차 또는 4차 아미노 그룹을 갖는 메타크릴레이트, 양이온으로 변형된 아크릴레이트, 젤라틴숙시네이트, 셀락, 가교결합된 젤라틴 및 프탈화된 젤라틴으로 이루어진 그룹으로부터 선택된 조성물.The water-soluble protein of any one of the preceding claims, wherein the hydrophilic polymer does not form a dispersed phase, comprising: a water soluble protein selected from animal gelatin, vegetable gelatin, sunflower protein, soy protein, cotton seed protein, peanut protein, rapeseed protein, acrylated protein; Practically water soluble polysaccharides, alkyl starches, hydroxyalkyl starch and hydroxyalkylalkyl starch, starch esters and hydroxyalkyl starch esters, carboxyalkyl starch, carboxyalkylalkyl starch alkyl cellulose, hydroxyalkyl cellulose and hydroxyalkylalkyl cellulose , Cellulose esters and hydroxyalkyl cellulose esters, carboxyalkyl celluloses, carboxyalkylalkyl celluloses and alkali metal salts thereof, polyacrylic acid and polyacrylic acid esters, polymethacrylic acid and polymethacrylic acid esters, polyvinyl alcohol, polyvinyl acetate phthalate (PVAP), polycrotonic acid; Polyitaconic acid, polymaleic acid; A composition selected from the group consisting of methacrylates having tertiary or quaternary amino groups which may be quaternized, cation modified acrylates, gelatin succinates, shellacs, crosslinked gelatins and phthalated gelatins. 전기한 항의 어느 한 항에 있어서, 친수성 중합체가 젤라틴인 조성물.The composition of claim 1 wherein the hydrophilic polymer is gelatin. 제1항 내지 제5항의 어느 한 항에 있어서, 친수성 중합체가 메틸전분, 하이드록시메틸전분, 하이드록시에틸전분, 하이드록시프로필 전분, 하이드록시에틸메틸전분, 하이드록시프로필메틸 전분, 하이드록시부틸메틸 전분, 전분 아세테이트프탈레이트 및 하디록시프로필메틸-전분 프탈레이트, 메틸셀룰로즈, 하이드록시메틸셀룰로즈, 하이드록시에틸 셀룰로즈, 하이드록시프로필 셀룰로즈, 하이드록시에틸메틸 셀룰로즈, 하이드록시프로필 메틸 셀룰로즈, 및 하이드록시부틸 메틸 셀룰로즈, 셀룰로즈 아세테이트프탈레이트 및 하이드록시프로필메틸 셀룰로즈 프탈레이트로 이루어진 그룹으로부터 선택된 조성물.The hydrophilic polymer according to any one of claims 1 to 5, wherein the hydrophilic polymer is methyl starch, hydroxymethyl starch, hydroxyethyl starch, hydroxypropyl starch, hydroxyethylmethyl starch, hydroxypropylmethyl starch, hydroxybutylmethyl. Starch, starch acetate phthalate and hydroxypropylmethyl-starch phthalate, methylcellulose, hydroxymethylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethylmethyl cellulose, hydroxypropyl methyl cellulose, and hydroxybutyl methyl cellulose , Cellulose acetate phthalate and hydroxypropylmethyl cellulose phthalate. 전기한 항의 어느 한 항에 있어서, 조성물의 건조 성분의 중량을 기준으로 하여 50중량%까지의 양으로 부가된 최소한 하나의 다른 친수성 중합체를 더 포함하는 조성물.The composition of claim 1, further comprising at least one other hydrophilic polymer added in an amount of up to 50% by weight, based on the weight of the dry components of the composition. 전기한 항의 어느 한 항에 있어서, 물의 함량이 총 조성물의 약 1-40중량%인 조성물.The composition of any one of the preceding claims wherein the content of water is about 1-40% by weight of the total composition. 전기한 항의 어느 한 항에 있어서, 분산상의 친수성 물질의 융점이 친수성 중합체의 유리전이 온도보다 높은 조성물.The composition of any one of the preceding claims wherein the melting point of the hydrophilic material of the dispersed phase is higher than the glass transition temperature of the hydrophilic polymer. 전기한 항의 어느 한 항에 있어서, 친수성 물질이 그의 중량의 1000배까지의 양으로 물을 흡수하는 조성물.The composition of claim 1 wherein the hydrophilic material absorbs water in an amount up to 1000 times its weight. 전기한 항의 어느 한 항에 있어서, 친수성 물질이 조성물내에 조성물 중량의 약0.1-약 4중량%, 바람직하게 약 0.1-약 2중량%, 더 바람직하게 약 0.3-약 2중량% 및 가장 바람직하게 약 0.5-약 1.5중량%의 농도로 존재하는 조성물.The method of claim 1, wherein the hydrophilic material is present in the composition in about 0.1% to about 4% by weight of the composition, preferably from about 0.1% to about 2% by weight, more preferably from about 0.3% to about 2% by weight and most preferably about A composition present at a concentration of 0.5-about 1.5% by weight. 전기한 항의 어느 한 항에 있어서, 친수성 물질이 셀룰로즈, 치틴, 전분 또는 치토산으로 이루어진 그룹으로부터 선택된 다당류로 이루어진 조성물.The composition of any one of the preceding claims wherein the hydrophilic material consists of a polysaccharide selected from the group consisting of cellulose, chitin, starch or chitosan. 제13항에 있어서, 다당류가 치환된 조성물.The composition of claim 13 wherein the polysaccharide is substituted. 전기한 항의 어느 한 항에 있어서, 다당류가 카복시-, 카복시알킬 및 이것의 염, 설포알킬- 및 이것의 염, 디알킬아미노알킬 및 이것의 4차 유도체로 이루어진 그룹으로부터 선택된 것으로 치환된 조성물.The composition of claim 1, wherein the polysaccharide is substituted with one selected from the group consisting of carboxy-, carboxyalkyl and salts thereof, sulfoalkyl- and salts thereof, dialkylaminoalkyl and quaternary derivatives thereof. 전기한 항의 어느 한 항에 있어서, 다당류가 카복시메틸셀룰로즈, 디에틸 아미노에틸 셀룰로즈, 트리에탄올아민 셀룰로즈, 폴리에틸렌이민 셀룰로즈 및 카복시메틸 전분으로 이루어진 그룹으로부터 선택된 조성물.The composition of claim 1 wherein the polysaccharide is selected from the group consisting of carboxymethylcellulose, diethyl aminoethyl cellulose, triethanolamine cellulose, polyethyleneimine cellulose and carboxymethyl starch. 제13항 내지 제16항의 어느 한 항에 있어서, 다당류가 실 또는 섬유이고 다당류의 길이가 약 10-약 500㎛, 바람직하게 약 20-30㎛, 및 가장 바람직하게 약 20-약 100㎛인 조성물.The composition according to claim 13, wherein the polysaccharide is a yarn or fiber and the polysaccharide has a length of about 10 to about 500 μm, preferably about 20 to 30 μm, and most preferably about 20 to about 100 μm. . 제13항 내지 제17항의 어느 한 항에 있어서, 다당류가 가교결합된 조성물.The composition of claim 13, wherein the polysaccharide is crosslinked. 전기한 항의 어느 한 항에 있어서, 다당류가 가교합된 카복시메틸 전분 및 이것의 염, 내부적으로 가교결합된 카복시메틸 셀룰로즈 및 이것의 염, 및 3차 또는 4차 아미노 그룹을 갖는 셀룰로즈아민으로 이루어진 조성물.The composition according to claim 1, wherein the polysaccharide consists of crosslinked carboxymethyl starch and salts thereof, internally crosslinked carboxymethyl cellulose and salts thereof, and celluloseamines having tertiary or quaternary amino groups. . 제13항에 있어서, 다당류가 풀루란 또는 풀루란 유도체인 방법.The method of claim 13, wherein the polysaccharide is pullulan or a pullulan derivative. 전기한 항의 어느 한항에 있어서, 풀루란 또는 이것의 유도체가 0.5-1.2정도까지 치환된 조성물.The composition according to any one of the preceding claims, wherein pullulan or a derivative thereof is substituted to about 0.5-1.2. 제1-제12항의 어느 한 항에 있어서, 친수성 물질이 내부적으로 가교결합된 폴리비닐피롤리돈 또는 이것의 염으로 이루어진 조성물.13. The composition of any one of claims 1-12, wherein the hydrophilic material consists of polyvinylpyrrolidone or a salt thereof crosslinked internally. 전기한 항의 어느 한 항에 있어서, 충전제, 이형제, 가소제, 안정제 및 착색제 같은 부가제를 더 포함하는 조성물.The composition of any one of the preceding claims further comprising additives such as fillers, mold release agents, plasticizers, stabilizers and colorants. 고체화된 친수성 중합체로 이루어진 매체 및 친수성 중합체로 이루어진 매체에 용해되지 않는 최소한 하나의 친수성 물질로 이루어진 상을 포함하며, 매체는 상에 대해 분산매체로서 작용하고, 상은 이와 마찬가지로 매체에 대해 분산상으로서 작용하며, 상은 이러한 상이 없는 조성물로 만들어진 용해 속도와 비교해 볼때 제품의 용해도를 증가시키기에 충분한 농도로 조성물내에 존재하는, 크기 안정성이 상당히 양호하고 용해성이 향상된 제품으로 만들어질 수 있는 물질로 구성된 조성물로부터 얻어진 성형가공제품.A medium consisting of a solidified hydrophilic polymer and a phase consisting of at least one hydrophilic material that does not dissolve in the medium consisting of a hydrophilic polymer, the medium acting as a dispersion medium for the phase and the phase likewise acting as a dispersion phase for the medium The phase is formed from a composition consisting of a material that can be made into a product with significantly good size stability and improved solubility that is present in the composition at a concentration sufficient to increase the solubility of the product as compared to the dissolution rate made with such a phaseless composition. Processed products. 제1항 내지 제23항의 어느 한 항에 따르는 조성물로 만들어진 제품.An article made of a composition according to claim 1. 제25항에 있어서, 제약학적 형태의 제품.The product of claim 25, in a pharmaceutical form. 분산상으로서 작용하는 물질을 용융물이 만들어지기 전이나 만들어지는 동안 또는 그후에 친수성 중합체에 부가하는 것으로 특징지어지고, 전기한 친수성 중합체를 분해되기에 충분한 시간동안 친수성 중합체의 유리전이온도 및 용융점보다 높은 온도까지 가열하는 것으로 이루어지는, 고체화된 친수성 중합체로 이루어진 매체 및 친수성 중합체로 이루어진 매체에 용해되지 않는 최소한 하나의 친수성 물질로 이루어진 상을 포함하며, 매체는 상에 대해 분산매체로서 작용하고, 상은 이와 마찬가지로 매체에 대해 분산상으로서 작용하며, 상은 이러한 상이 없는 조성물로 만들어진 용해속도와 비교해볼때 제품의 용해도를 증가시키기에 충분한 농도로 조성물내에 존재하는, 크기 안정성이 상당히 양호하고 용해성이 향상된 제품으로 만들어질 수 있는 물질로 구성된 조성물을 제조하는 방법.A substance which acts as a dispersed phase is characterized by adding to the hydrophilic polymer before, during or after the melt is made, and to a temperature higher than the glass transition temperature and melting point of the hydrophilic polymer for a time sufficient to decompose the aforementioned hydrophilic polymer. A medium consisting of a solidified hydrophilic polymer and a phase consisting of at least one hydrophilic material that does not dissolve in the medium consisting of a hydrophilic polymer, the medium acting as a dispersion medium for the phase and the phase likewise Acts as a disperse phase, and the phase can be made into a product with significantly good size stability and improved solubility present in the composition at a concentration sufficient to increase the solubility of the product as compared to the dissolution rate made with such a phase free composition. Method for producing a composition composed of a material. 제27항에 있어서, 친수성 중합체가 젤라틴인 방법.The method of claim 27, wherein the hydrophilic polymer is gelatin. 사출성형, 취입성형, 압출, 공-압출, 압축성형, 진공성형, 발포 및 열성형으로부터 선택된, 조절된 물 및 압력 조건하에서 제1항 내지 제23항의 어느 한 항에 따르는 조성물을 성형하는 방법.24. A method of molding a composition according to any one of claims 1 to 23 under controlled water and pressure conditions, selected from injection molding, blow molding, extrusion, co-extrusion, compression molding, vacuum molding, foaming and thermoforming. 제29항의 방법에 의해 만들어진 제품.A product made by the method of claim 29. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019910014321A 1990-08-30 1991-08-20 New Compositions Composed of Hydrophilic Polymers and Different Hydrophilic Materials KR920004485A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57546390A 1990-08-30 1990-08-30
US575,463 1990-08-30

Publications (1)

Publication Number Publication Date
KR920004485A true KR920004485A (en) 1992-03-27

Family

ID=24300428

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910014321A KR920004485A (en) 1990-08-30 1991-08-20 New Compositions Composed of Hydrophilic Polymers and Different Hydrophilic Materials

Country Status (7)

Country Link
JP (1) JPH055065A (en)
KR (1) KR920004485A (en)
CA (1) CA2049524A1 (en)
DE (1) DE4127522A1 (en)
FR (1) FR2666340A1 (en)
GB (1) GB2255344B (en)
IT (1) IT1249443B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3752710B2 (en) * 1994-11-01 2006-03-08 東レ株式会社 Resin composition, antibacterial method and antifungal method
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
GB2378705B (en) 1998-08-26 2003-03-26 Pvaxx Technologies Ltd PVA-Containing compositions
JP3672008B2 (en) * 1999-01-20 2005-07-13 シオノギクオリカプス株式会社 Hard capsule and method for producing the same
AU778049B2 (en) * 1999-08-09 2004-11-11 Dainippon Sumitomo Pharma Co., Ltd. Solid preparation containing chitosan powder and process for producing the same
EP1253932B1 (en) * 2000-02-08 2005-04-27 Allergan, Inc. Botulinum toxin pharmaceutical compositions
GB0005016D0 (en) * 2000-03-01 2000-04-26 Jumik Technologies Limited PVA-Containing compositions
US7985420B2 (en) 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
EP1580229A1 (en) * 2004-03-22 2005-09-28 Warner-Lambert Company Llc Biopolymer compositons and products thereof
US7781506B2 (en) * 2007-01-26 2010-08-24 E.I. Du Pont De Nemours And Company Poly(vinyl alcohol) composition comprising a polyol
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784390A (en) * 1971-07-23 1974-01-08 Hayashibara Biochem Lab Shaped bodies of pullulan and their use
US3865603A (en) * 1972-07-17 1975-02-11 Nat Starch Chem Corp Modified starch-extended gelatin compositions
US4655840A (en) * 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
EG16027A (en) * 1982-03-26 1986-12-30 Warner Lambert Co Hydrophilic polymer composition for injection molding
BG46154A3 (en) * 1983-02-18 1989-10-16 Warner Lambert Co Method for preparing of capsules
CH664938A5 (en) * 1983-10-20 1988-04-15 Warner Lambert Co PRINTED ARTICLES.
DE3529694A1 (en) * 1985-08-20 1987-02-26 Scherer Gmbh R P GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION
CH674370A5 (en) * 1987-03-27 1990-05-31 Pier Luigi Prof Dr Luisi
GB8721455D0 (en) * 1987-09-11 1987-10-21 Lilly Industries Ltd Capsules
JPH062665B2 (en) * 1987-10-06 1994-01-12 新田ゼラチン株式会社 Gelatin composition
GB2218994B (en) * 1988-05-26 1992-01-15 Warner Lambert Co New polymer composition
DE3827061C1 (en) * 1988-08-10 1990-02-15 Deutsche Gelatine-Fabriken Stoess & Co Gmbh, 6930 Eberbach, De
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule

Also Published As

Publication number Publication date
IT1249443B (en) 1995-02-23
GB2255344A (en) 1992-11-04
ITRM910622A1 (en) 1993-02-20
CA2049524A1 (en) 1992-03-01
GB9117938D0 (en) 1991-10-09
FR2666340A1 (en) 1992-03-06
ITRM910622A0 (en) 1991-08-20
DE4127522A1 (en) 1992-03-05
GB2255344B (en) 1994-07-20
JPH055065A (en) 1993-01-14

Similar Documents

Publication Publication Date Title
KR920004485A (en) New Compositions Composed of Hydrophilic Polymers and Different Hydrophilic Materials
CA1334224C (en) Polymeric materials made from destructurized starch and at least one synthetic thermoplastic polymeric material
EP1315479B2 (en) Pectin film compositions
KR0130073B1 (en) Process of fioming shaped article from starch and such airticles
US5095054A (en) Polymer compositions containing destructurized starch
US4365060A (en) Enterosoluble capsules
IE83254B1 (en) Polymeric materials made from destructurized starch and at least one synthetic thermoplastic polymeric material
JP3201609B2 (en) Molded articles obtained from thermoplastic starch melt
AU625833B2 (en) A polymer composition comprising a hydrophilic polymer and a thermoplastic polymer
AU2002210449A1 (en) Pectin film compositions
RU2008136767A (en) PHARMACEUTICAL COMPOSITION FLUVASTATINE SODIUM
CN103980717A (en) Gelatin-natural polysaccharide blending modified capsule
CN103874727B (en) The formulation of injection moulding
JP2003055198A (en) Soft capsule shell
JP2021025145A (en) Granular pulp
CN107669653A (en) A kind of felodipine solid disperses sustained release preparation and preparation method thereof
PL66155B1 (en) should:
JPH04164025A (en) Production of sustained release tablet

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid